Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Article in Clinical Research in Cardiology Supplements (March 2019)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes
Article in Current Cardiology Reviews (August 2017)
Statins and Niacin: The End of Residual Risk Therapy?
Book chapter (January 2015)